Product Images Levetiracetam

This is a prescription drug called LevETIRAcetam with 500 mg of dosage. It is a package of 30 tablets with directions for use specified in the package insert. The drug is manufactured by Lupin Pharma located in Baltimore, MD, and was repackaged by RemedyRepack Inc., Indiana, PA for purchase. The NDC number is 70518-1772-00 and it has a LOT number, but no expiration date is specified. The package insert should be consulted for dosage instructions, and the tablets should be stored at a temperature of 20-25°C (88-77°F).*

This text provides a simple formula for calculating the total daily dose of medication based on the patient's weight and the daily dose in milligrams per kilogram. The medication concentration is given as 100 mg/mL.*

This is a formula for estimating the creatinine clearance rate (CLer) in female patients based on their age, weight, and serum creatinine levels. The formula takes into account the patient's body surface area (BSA) for further adjustment.*

This appears to be a graph or chart that displays percentages related to Levetiracetam medication at different dosages. The dosages compared are 1000 mg/day and 3000 mg/day, and there are percentage values for a range of levels between 0% and 45%. The meaning or context of the percentages is not available from the text provided.*

This appears to be a table showing the percentage of patients in different treatment groups (placebo, 1000mg/day of levetiracetam, and 2000mg/day of levetiracetam) and the percentage of those patients experiencing certain outcomes. The outcomes are not specified in the given text.*

This appears to be a table showing the percentage of patients in a study who received either a placebo or levetiracetam. The first column lists the percentages, while the second column indicates the sample size for each treatment group (N=7 for placebo and N=101 for levetiracetam). However, it is not entirely clear what the percentages are referring to (e.g. response rates, adverse events, etc.) as there is no accompanying text or column headings.*

This is a clinical study result showing the percentage of patients who received Placebo and Levetiracetam. Of the 51 patients who received Placebo, 19.6% showed the desired effect, while of the 58 patients who received Levetiracetam, 43.1% showed the desired effect.*

This is a table that shows the percentage of patients treated with placebo and levetiracetam. There are various percentages shown, ranging from 0% to 100%. The table shows that out of 84 patients treated with placebo, none showed improvement in their condition. In contrast, out of 79 patients treated with levetiracetam, 45.2% showed improvement in their condition.*

This is a prescription drug made by Lupin Pharma to treat seizures in adults and children. The drug is in tablet form and has a strength of 500mg. The package contains 60 tablets, and the directions for use are contained in the package insert. The medication should be kept out of the reach of children and stored at temperatures between 20-25°C. The product was repackaged by RemedyRepack Inc. located in Indiana, PA 15701.*